OREANDA-NEWS. A British regulator has recommended that people under the age of thirty should not be vaccinated with AstraZeneca if possible due to rare cases of blood clots.

"The Joint Vaccination Committee recommends that a different COVID-19 vaccine, if possible, be offered to adults under 30 years of age without chronic diseases that increase the risk of acute COVID-19," the committee said in a statement.

"The benefits of vaccination with AstraZeneca continue to outweigh the risks. The likelihood of side effects remains very small," said Dr June Ren, head of the UK Medicines Agency, at a press conference.

Earlier on Wednesday, the drug regulator - the European Medicines Agency - said it admits that the AstraZeneca vaccine could be linked to blood clots, which is rare but should be listed as a rare side effect of the drug.

These side effects occur primarily in women under the age of 55. The reasons for this reaction remain unknown and have yet to be established. Cavaleri noted that this work is far from complete.

Information about possible complications after vaccination with AstraZeneca appeared in early March. Thus, the British Office for the Control of Medicines and Medical Devices reported 30 cases of thrombosis after the use of the AstraZeneca vaccine, RIA Novosti clarifies. Several European countries have temporarily suspended the use of this drug.